cilastatin has been researched along with Escherichia coli Infections in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (33.33) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
Duttaroy, DD; González Patzán, LD; Kreidly, Z; Lipka, J; Sable, C; Stricklin, D; Vazquez, JA | 1 |
Ackermann, G; Beer, J; Blatz, R; Rodloff, AC; Schaumann, R | 1 |
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
Akamo, Y; Manabe, T; Mizokami, M; Mizuno, I; Mohri, N; Shinagawa, N; Takeyama, H; Yuasa, H | 1 |
Casewell, M; Fagan, E; Gimson, A; Philpott-Howard, J; Rolando, N; Sahathevan, M; Westaby, D; Williams, R | 1 |
Ariga, K; Shinagawa, N; Suzuki, K; Yamakoshi, M; Yamamoto, T | 1 |
Hatakeyama, N; Horiguchi, A; Ikeuchi, K; Oyama, M | 1 |
Abe, K; Oishi, Y; Ueda, M; Wada, T | 1 |
Atkinson, AM; Teale, DM | 1 |
Kletchko, S; Nagappan, R | 1 |
Guiot, HF; Mattie, H; van Furth, R; van Ogtrop, ML | 1 |
Baron, S; Bégué, P; Challier, P; Fontaine, JL; Lasfargues, G; Quinet, B | 1 |
Brook, I | 1 |
Hashizume, T; Kemi, M; Komatsu, T; Ogashiwa, M; Okumoto, Y; Takase, Z | 1 |
Satoh, K; Watanabe, A | 1 |
Alpert, G; Bloh, AM; Campos, JM; Connor, E; Dagan, R; Plotkin, SA; Powell, KR | 1 |
Kim, KS | 1 |
1 review(s) available for cilastatin and Escherichia coli Infections
Article | Year |
---|---|
[A case of psoas abscess associated in the elderly].
Topics: Aged; Aged, 80 and over; Cilastatin; Diabetes Complications; Drainage; Drug Therapy, Combination; Escherichia coli Infections; Humans; Imipenem; Male; Proteus Infections; Proteus mirabilis; Psoas Abscess; Sepsis | 1996 |
2 trial(s) available for cilastatin and Escherichia coli Infections
Article | Year |
---|---|
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cilastatin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyelonephritis; Urinary Tract Infections | 2012 |
Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli Infections; Esophageal and Gastric Varices; Esophageal Diseases; Esophagoscopy; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Sclerotherapy; Staphylococcal Infections; Staphylococcus aureus | 1993 |
15 other study(ies) available for cilastatin and Escherichia coli Infections
Article | Year |
---|---|
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA, Bacterial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Imipenem; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
Perforated acute appendicitis in a patient with AIDS/HIV infection: report of a case.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Appendectomy; Appendicitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Fever of Unknown Origin; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunization, Passive; Intestinal Perforation; Male; Postoperative Complications; Rupture, Spontaneous | 1995 |
[A case of septic shock following incarceration of the penis].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; gamma-Globulins; Humans; Imipenem; Male; Methylprednisolone; Minocycline; Penis; Shock, Septic | 1998 |
[A case of effective endotoxin adsorption therapy for septic shock due to acute pyelonephritis].
Topics: Acute Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxins; Escherichia coli; Escherichia coli Infections; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Pyelonephritis; Shock, Septic; Sorption Detoxification; Treatment Outcome; Ureteral Calculi | 2000 |
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis | 1992 |
Bilateral emphysematous pyelonephritis resolving to medical therapy.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed | 1992 |
Relation between the therapeutic efficacy of imipenem in an experimental infection in granulocytopenic mice and its effect on murine intestinal microbial ecology.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Drug Combinations; Escherichia coli Infections; Imipenem; Injections, Subcutaneous; Intestines; Male; Mice; Muscular Diseases; Specific Pathogen-Free Organisms; Thigh | 1990 |
[Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Imipenem; Infant, Newborn; Male; Pseudomonas Infections; Serratia | 1989 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.
Topics: Ampicillin; Animals; Cefazolin; Cilastatin; Cyclopropanes; Drug Combinations; Drug Evaluation, Preclinical; Endometritis; Enterococcus faecalis; Escherichia coli Infections; Female; Imipenem; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Inbred Strains; Streptococcal Infections; Thienamycins | 1987 |
[A clinical study on imipenem/cilastatin sodium in the field of pediatrics].
Topics: Bacterial Infections; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Escherichia coli Infections; Female; Gastroenteritis; Haemophilus Infections; Humans; Imipenem; Infant; Male; Neisseria; Respiratory Tract Infections; Streptococcal Infections; Thienamycins; Urinary Tract Infections | 1986 |
Imipenem/cilastatin for the treatment of infections in hospitalized children.
Topics: Arthritis, Infectious; Bacterial Infections; Cellulitis; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Escherichia coli Infections; Female; Haemophilus Infections; Hospitalization; Humans; Imipenem; Infant; Kidney Diseases; Lymphadenitis; Male; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thienamycins; Wound Infection | 1985 |
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins | 1985 |